Your leading voice in digital health news
Twitter X Logo

European Medicines Agency qualifies first AI tool to diagnose inflammatory liver disease 

3 April 2025
By Dawn O'Shea
The European Medicines Agency (EMA) has issued the first Qualification Opinion (QO) on an innovative development methodology based on artificial intelligence (AI). The tool, called AIM-NASH, helps pathologists to analyse liver biopsy scans and identify the severity of metabolic dysfunction associated steatohepatitis (MASH), formerly known as non-alcoholic steatohepatitis (NASH), among participants in clinical trials. The […]

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Copyright © 2025 Pulse IT Communications Pty Ltd. No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher. If your organisation is featured in a Pulse+IT article you can purchase the permission to reproduce the article here.
Website Design by Get Leads AU.

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down